Thu, September 6, 2018
Wed, September 5, 2018
Tue, September 4, 2018
Fri, August 31, 2018
Thu, August 30, 2018
Wed, August 29, 2018
Tue, August 28, 2018
Mon, August 27, 2018
Fri, August 24, 2018
Thu, August 23, 2018
Wed, August 22, 2018
Tue, August 21, 2018
Mon, August 20, 2018
Fri, August 17, 2018
Thu, August 16, 2018
Wed, August 15, 2018
Tue, August 14, 2018

Charles Duncan Initiated (ACAD) at Buy and Held Target at $25 on, Aug 23rd, 2018


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-25-on-aug-23rd-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation



Charles Duncan of Cantor Fitzgerald, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy and Held Target at $25 on, Aug 23rd, 2018.

Charles has made no other calls on ACAD in the last 4 months.



There are 2 other peers that have a rating on ACAD. Out of the 2 peers that are also analyzing ACAD, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matteis Paul of "Stifel" Maintained at Hold with Decreased Target to $14 on, Thursday, August 9th, 2018


This is the rating of the analyst that currently disagrees with Charles


  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $27 on, Thursday, August 9th, 2018

Publication Contributing Sources